Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of medical and surgical complications, and subsequent mortality, after hip fracture surgery : a nationwide cohort study from 2010 to 2021.

The bone & joint journal·2026
Same author

Mental disorders and osteoporosis treatment in patients with hip fracture-a Danish population-based cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Risks of Myocardial Infarction and Mortality in Patients with Incident Rheumatoid Arthritis Compared with a Matched General Population: A Danish Nationwide Cohort Study.

Clinical epidemiology·2026
Same author

Postoperative mobility is associated with risk of reoperation and increased mortality after hip fracture: a nationwide cohort study of 33,486 patients.

Acta orthopaedica·2026
Same author

Ugeskrift for laeger·2026
Same author

Perspective: Fragility Fracture Network in the Nordic Orthopaedic Federations countries - the role of orthopaedic surgeons.

Acta orthopaedica·2026
Same journal

Stress Disorders and Human Papillomavirus-Related Cancer Rates: A Population-Based Cohort Study in Denmark.

Clinical epidemiology·2026
Same journal

Making Statistics Clinically Meaningful.

Clinical epidemiology·2026
Same journal

Sensitivity of Administrative Coding for Heart Disease in Pregnancy.

Clinical epidemiology·2026
Same journal

Cohort Profile: The Central Denmark Cancer Cohort.

Clinical epidemiology·2026
Same journal

The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study.

Clinical epidemiology·2026
Same journal

Pregnancy Outcomes in Women with Type 1 Diabetes by Socioeconomic and Mental Health Disadvantages.

Clinical epidemiology·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.5K

The Danish Sarcoma Database.

Peter Holmberg Jørgensen1, Gunnar Schwarz Lausten2, Alma B Pedersen3

  • 1Tumor Section, Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus.

Clinical Epidemiology
|November 9, 2016
PubMed
Summary
This summary is machine-generated.

The Danish Sarcoma Database collects data on all sarcoma patients in Denmark since 2009. This population-based registry monitors treatment quality, complications, and outcomes for research and improved patient care.

Keywords:
online databasepopulation-based databasequality indicatorssarcomaskeletal and ekstraskeletal

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.4K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K

Related Experiment Videos

Last Updated: Mar 12, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.5K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.4K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K

Area of Science:

  • Oncology
  • Public Health
  • Medical Informatics

Background:

  • Sarcomas are rare cancers requiring specialized treatment.
  • Monitoring treatment quality is crucial for improving patient outcomes.
  • A centralized database facilitates comprehensive data collection and analysis.

Approach:

  • Established a population-based registry for all Danish sarcoma patients (skeletal and extraskeletal) since 2009.
  • Collected detailed data on patient demographics, tumor characteristics, treatment modalities, and outcomes.
  • Integrated quality indicators for hospital performance comparison and adherence to international standards.

Key Points:

  • The database captures symptom onset, referral dates, diagnostic information, and treatment specifics (surgery, radiation, chemotherapy).
  • It records complications, local recurrence, metastases, and comorbidity for comprehensive patient profiling.
  • Demographic data, ICD-10 codes, TNM staging, and mortality data are linked via the Danish Civil Registration System.

Conclusions:

  • The Danish Sarcoma Database is a valuable tool for monitoring sarcoma incidence and treatment quality.
  • It enables continuous improvement of care through local, national, and international benchmarking.
  • The database serves as a critical resource for research into factors influencing sarcoma patient prognosis.